(Q45260619)

11 December 2017

title

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction (English)

1 reference

11 December 2017

author

Antonio Alcaraz Asensio

7

1 reference

11 December 2017

3

Mark Emberton

1 reference

11 December 2017

author name string

R Jeroen A van Moorselaar

1

1 reference

11 December 2017

Rudolf Hartung

2

1 reference

11 December 2017

Niels Harving

4

1 reference

11 December 2017

Haim Matzkin

5

1 reference

11 December 2017

Mostafa Elhilali

6

1 reference

11 December 2017

Guy Vallancien

8

1 reference

11 December 2017

ALF-ONE Study Group

9

1 reference

11 December 2017

publication date

1 March 2005

1 reference

11 December 2017

1 reference

11 December 2017

volume

95

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

603-608

1 reference

Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Cavernous and systemic plasma levels of norepinephrine and epinephrine during different penile conditions in healthy men and patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Comparison of the relaxant effects of alfuzosin, phentolamine and sildenafil on rabbit isolated corpus cavernosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05347.X

10.1111/J.1464-410X.2005.05347.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference